Activation of the mitochondrial caspase cascade in the absence of protein synthesis does not require c-Jun N-terminal kinase

Arch Biochem Biophys. 2002 Sep 15;405(2):231-40. doi: 10.1016/s0003-9861(02)00399-5.

Abstract

Prolonged activation of the c-Jun N-terminal kinase (JNK) has been suggested as a signal for apoptosis in response to a wide variety of stimuli. Using three cytocidal RNA or protein synthesis inhibitors (actinomycin D, anisomycin, and emetine), the potential role of JNK in activation of the mitochondrial apoptotic cascade was investigated in A549-S cells. Protein synthesis inhibition per se was not the cause of cell death as cycloheximide induced only growth arrest. All the cytocidal inhibitors induced cytochrome c release and caspases 9 activation within hours, but only anisomycin caused persistent JNK activation. Although, the JNK inhibitor, SP600125, inhibited JNK-dependent anisomycin-induced c-Jun phosphorylation, it was ineffective in preventing anisomycin-induced caspase activation and cell death. Thus, all three lethal macromolecule synthesis inhibitors can activate the mitochondrial apoptotic machinery independent of JNK activation, demonstrating that the mitochondrial apoptotic pathway can be activated independently of the JNK pathway in the absence of protein synthesis.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anisomycin / pharmacology
  • Anthracenes / pharmacology
  • Apoptosis / drug effects
  • Caspase 9
  • Caspases / drug effects
  • Caspases / metabolism*
  • Cytochrome c Group / drug effects
  • Cytochrome c Group / metabolism
  • Dactinomycin / pharmacology
  • Dose-Response Relationship, Drug
  • Emetine / pharmacology
  • Enzyme Activation / drug effects
  • Enzyme Inhibitors / pharmacology
  • Humans
  • JNK Mitogen-Activated Protein Kinases
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / drug effects
  • Mitogen-Activated Protein Kinases / metabolism*
  • Nucleic Acid Synthesis Inhibitors / pharmacology
  • Protein Biosynthesis*
  • Protein Synthesis Inhibitors / pharmacology
  • Proteins / drug effects
  • Time Factors

Substances

  • Anthracenes
  • Cytochrome c Group
  • Enzyme Inhibitors
  • Nucleic Acid Synthesis Inhibitors
  • Protein Synthesis Inhibitors
  • Proteins
  • Dactinomycin
  • pyrazolanthrone
  • Anisomycin
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases
  • CASP9 protein, human
  • Caspase 9
  • Caspases
  • Emetine